Femoral Versus Radial Access for Primary PCI (SAFARI-STEMI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01398254|
Recruitment Status : Completed
First Posted : July 20, 2011
Last Update Posted : January 29, 2019
Ottawa Heart Institute Research Corporation
Information provided by (Responsible Party):
Michel Le May, Ottawa Heart Institute Research Corporation
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||December 2018|
|Actual Study Completion Date :||January 16, 2019|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Marbach JA, Wells G, Santo PD, So D, Chong AY, Russo J, Labinaz M, Dick A, Froeschl M, Glover C, Hibbert B, Marquis JF, MacDougall A, Kass M, Paddock V, Quraishi AUR, Chandrasekhar J, Ghosh N, Bernick J, Le May M. Acute kidney injury after radial or femoral artery access in ST-segment elevation myocardial infarction: AKI-SAFARI. Am Heart J. 2021 Apr;234:12-22. doi: 10.1016/j.ahj.2020.12.019. Epub 2021 Jan 7.
Le May M, Wells G, So D, Chong AY, Dick A, Froeschl M, Glover C, Hibbert B, Marquis JF, Blondeau M, Osborne C, MacDougall A, Kass M, Paddock V, Quraishi A, Labinaz M. Safety and Efficacy of Femoral Access vs Radial Access in ST-Segment Elevation Myocardial Infarction: The SAFARI-STEMI Randomized Clinical Trial. JAMA Cardiol. 2020 Feb 1;5(2):126-134. doi: 10.1001/jamacardio.2019.4852. Erratum in: JAMA Cardiol. 2020 Feb 1;5(2):236. JAMA Cardiol. 2020 Jul 29;:. JAMA Cardiol. 2020 Sep 1;5(9):1071.